Skip to content
healthcare.dev
Get a free key

Doxazosin mesylate

NDC 71610-965, doxazosin mesylate, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-965
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA019668
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-965 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE4 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
71610-965-537161009655360 TABLET in 1 BOTTLE (71610-965-53)
71610-965-607161009656090 TABLET in 1 BOTTLE (71610-965-60)
71610-965-7071610096570120 TABLET in 1 BOTTLE (71610-965-70)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/445dc831-1960-4b25-e063-6294a90a6efd

Use it

Look up 71610-965 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-965 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-965. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.